Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

$22.49

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Price to Earnings (P/E)
since 2005

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Abiomed Inc., P/E, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of Abiomed Inc. Annual Report.

The financial data reveals notable developments in share price, earnings per share (EPS), and price-to-earnings (P/E) ratios over the seventeen-year period under review.

Share Price
The share price demonstrates considerable volatility with an overall upward trajectory. Initial years show moderate fluctuations between approximately $7.43 and $22.17 until 2014. From 2014 onward, a significant increase is observed, peaking notably in 2018 at $394.46. Following this peak, the share price declined substantially, settling around $235.75 by 2022. This pattern indicates periods of both rapid investor optimism and subsequent corrections.
Earnings Per Share (EPS)
EPS figures indicate a transition from consistent losses in earlier years (2005-2007) toward profitability starting around 2011. The early financial difficulties are evidenced by negative EPS values reaching as low as -$1.24. A positive EPS emerges in 2012 and generally trends upward with some fluctuations. Significant increases are observed in 2015 at $2.72 and in 2019 at $5.74, illustrating improved operational performance. However, the most recent years show a slight decrease, declining to $3.00 by 2022.
Price-to-Earnings (P/E) Ratio
The P/E ratio is absent in early periods due to negative or negligible earnings. From 2013 onwards, it becomes available and varies widely. Initially, the P/E is very high, for example, 520.81 in 2013, reflecting low earnings relative to share price. Subsequent years feature fluctuations between roughly 22 and 156, indicating varying investor expectations and market sentiments. The P/E ratio remains elevated throughout, which may suggest high investor confidence in future growth despite earnings volatility.

In summary, the data depicts an evolution from an unprofitable phase with low and volatile share prices toward a phase characterized by substantial growth in share price and earnings, albeit accompanied by considerable valuation fluctuations. The high and volatile P/E ratios in later years emphasize speculative components or anticipated future growth embedded in the market valuation.


Comparison to Competitors

Abiomed Inc., P/E, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).


Comparison to Sector (Health Care Equipment & Services)

Abiomed Inc., P/E, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).


Comparison to Industry (Health Care)